Fox Chase Cancer Center News

PHILADELPHIA (May 31, 2023)—Cystic renal masses are a common type of kidney lesion that are generally considered to be low-risk and unlikely to spread beyond the kidney. Now a new study from Fox Chase Cancer Center that was featured on the cover of the Journal of Urology, published by Wolters Kluwer sheds more light on these lesions.

PHILADELPHIA (May 30, 2023)—Fox Chase Cancer Center has been accredited by the Smoking Treatment Accreditation & Recognition (STAR) program, a tobacco treatment initiative funded through a grant from the Pennsylvania Department of Health.

PHILADELPHIA (May 30, 2023)—Patients with muscle-invasive bladder cancer who receive fewer than three cycles of chemotherapy prior to bladder removal surgery face higher risk of recurrence and worse survival outcomes. That’s according to research from Temple Health and Fox Chase Cancer Center that will be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.

PHILADELPHIA (May 26, 2023) — Management of chronic lymphocytic leukemia (CLL) is a rapidly evolving field, so choosing between the growing number of effective, available therapies can be challenging for both physicians and patients.

PHILADELPHIA (May 24, 2023)— “SPEECH amplifies fundamental purposes at Temple’s core: Inclusive, accessible excellence in research, education, workforce development, and community engagement,” said JoAnne Epps, Acting Temple University President, during last week’s exciting gathering at the Lewis Katz School of Medicine.

PHILADELPHIA (May 22, 2023)—Fox Chase Cancer Center’s Mary Daly, MD, PhD, FACP, a professor in the Department of Clinical Genetics and the Timothy R. Talbot Jr. Chair in Cancer Research, was recently recognized as the first recipient of the BRCA Impact Award from Penn Medicine’s Basser Center for BRCA.

PHILADELPHIA (May 18, 2023)—Austin D. Williams, MD, MSEd, an assistant professor in the Department of Surgical Oncology at Fox Chase Cancer Center, received the Best Poster Award at the recent 24th Annual Meeting of the American Society of Breast Surgeons.

PHILADELPHIA (May 12, 2023)—As the enzyme telomerase is being formed within cells, it dwells within a specific cell compartment. Scientists have long thought that these compartments served as a kind of greenhouse, cradling the enzyme’s maturation and function. Now a new study from researchers at Fox Chase Cancer Center has found that they can also act as prisons.